Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

How do GPs and patients share the responsibility for cancer safety netting follow-up actions? A qualitative interview study of GPs and patients in Oxfordshire, UK.

Evans J, Macartney JI, Bankhead C, Albury C, Jones D, Ziebland S, Nicholson BD.

BMJ Open. 2019 Sep 12;9(9):e029316. doi: 10.1136/bmjopen-2019-029316.

2.

General practitioners' awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey.

Von Wagner C, Stoffel ST, Freeman M, Laszlo HE, Nicholson BD, Sheringham J, Szinay D, Hirst Y.

BMJ Open. 2019 Apr 11;9(4):e025737. doi: 10.1136/bmjopen-2018-025737.

3.

Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.

Shinkins B, Primrose JN, Pugh SA, Nicholson BD, Perera R, James T, Man D.

Br J Surg. 2019 May;106(6):728. doi: 10.1002/bjs.11175. No abstract available.

PMID:
30973997
4.

Patient consultation rate and clinical and NHS outcomes: a cross-sectional analysis of English primary care data from 2.7 million patients in 238 practices.

Lay-Flurrie S, Mathieu E, Bankhead C, Nicholson BD, Perera-Salazar R, Holt T, Hobbs FDR, Salisbury C; NIHR School for Primary Care Research, Nuffield Department of Primary Care Health Sciences, University of Oxford.

BMC Health Serv Res. 2019 Apr 6;19(1):219. doi: 10.1186/s12913-019-4036-y.

5.

Faecal immunochemical (rule-in) testing in general practice.

Bailey SE, van Melle MA, Nicholson BD.

Br J Gen Pract. 2019 Apr;69(681):178. doi: 10.3399/bjgp19X702173. No abstract available.

PMID:
30923144
6.

The internal validation of weight and weight change coding using weight measurement data within the UK primary care Electronic Health Record.

Nicholson BD, Aveyard P, Hamilton W, Bankhead CR, Koshiaris C, Stevens S, Hobbs FD, Perera R.

Clin Epidemiol. 2019 Jan 25;11:145-155. doi: 10.2147/CLEP.S189989. eCollection 2019.

7.

The diagnostic performance of current tumour markers in surveillance for recurrent testicular cancer: A diagnostic test accuracy systematic review.

Nicholson BD, Jones NR, Protheroe A, Joseph J, Roberts NW, Van den Bruel A, Fanshawe TR.

Cancer Epidemiol. 2019 Apr;59:15-21. doi: 10.1016/j.canep.2019.01.001. Epub 2019 Jan 15. Review.

PMID:
30658216
8.

National cancer control plans.

Nicholson BD, Shinkins B, Price S, Verbakel JY, Merriel S; Society of Academic Primary Care Cancer Special Interest Group.

Lancet Oncol. 2018 Dec;19(12):e665. doi: 10.1016/S1470-2045(18)30830-1. No abstract available.

PMID:
30507425
9.

The elusive diagnosis of cancer: testing times.

Nicholson BD, Perera R, Thompson MJ.

Br J Gen Pract. 2018 Nov;68(676):510-511. doi: 10.3399/bjgp18X699461. No abstract available. Erratum in: Br J Gen Pract. 2019 Apr;69(681):178.

PMID:
30361301
10.

Attitudes towards faecal immunochemical testing in patients at increased risk of colorectal cancer: an online survey of GPs in England.

von Wagner C, Stoffel S, Freeman M, Laszlo H, Nicholson BD, Sheringham J, Szinay D, Hirst Y.

Br J Gen Pract. 2018 Nov;68(676):e757-e764. doi: 10.3399/bjgp18X699413. Epub 2018 Oct 8.

11.

The mapping of cancer incidence and mortality trends in the UK from 1980-2013 reveals a potential for overdiagnosis.

Oke JL, O'Sullivan JW, Perera R, Nicholson BD.

Sci Rep. 2018 Oct 2;8(1):14663. doi: 10.1038/s41598-018-32844-x.

12.

Trends in Cancer Antigen 125 testing 2003-2014: A primary care population-based cohort study using laboratory data.

Nicholson BD, Lee MM, Wijeratne D, James T, Shine B, Oke JL.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12914. doi: 10.1111/ecc.12914. Epub 2018 Sep 20.

PMID:
30238522
13.

Direct access cancer testing in primary care: a systematic review of use and clinical outcomes.

Smith CF, Tompson AC, Jones N, Brewin J, Spencer EA, Bankhead CR, Hobbs FR, Nicholson BD.

Br J Gen Pract. 2018 Sep;68(674):e594-e603. doi: 10.3399/bjgp18X698561. Epub 2018 Aug 13.

14.

Early detection of multiple myeloma in primary care using blood tests: a case-control study in primary care.

Koshiaris C, Van den Bruel A, Oke JL, Nicholson BD, Shephard E, Braddick M, Hamilton W.

Br J Gen Pract. 2018 Sep;68(674):e586-e593. doi: 10.3399/bjgp18X698357. Epub 2018 Aug 13.

15.

General practitioner referrals to one-stop clinics for symptoms that could be indicative of cancer: a systematic review of use and clinical outcomes.

Friedemann Smith C, Tompson A, Holtman GA, Bankhead C, Gleeson F, Lasserson D, Nicholson BD.

Fam Pract. 2019 May 23;36(3):255-261. doi: 10.1093/fampra/cmy069.

16.

Medications that reduce emergency hospital admissions: an overview of systematic reviews and prioritisation of treatments.

Bobrovitz N, Heneghan C, Onakpoya I, Fletcher B, Collins D, Tompson A, Lee J, Nunan D, Fisher R, Scott B, O'Sullivan J, Van Hecke O, Nicholson BD, Stevens S, Roberts N, Mahtani KR.

BMC Med. 2018 Jul 26;16(1):115. doi: 10.1186/s12916-018-1104-9. Review.

17.

Quantifying intervals to diagnosis in myeloma: a systematic review and meta-analysis.

Koshiaris C, Oke J, Abel L, Nicholson BD, Ramasamy K, Van den Bruel A.

BMJ Open. 2018 Jun 22;8(6):e019758. doi: 10.1136/bmjopen-2017-019758.

18.

GPs' understanding and practice of safety netting for potential cancer presentations: a qualitative study in primary care.

Evans J, Ziebland S, MacArtney JI, Bankhead CR, Rose PW, Nicholson BD.

Br J Gen Pract. 2018 Jul;68(672):e505-e511. doi: 10.3399/bjgp18X696233. Epub 2018 May 8.

19.

Responsibility for follow-up during the diagnostic process in primary care: a secondary analysis of International Cancer Benchmarking Partnership data.

Nicholson BD, Goyder CR, Bankhead CR, Toftegaard BS, Rose PW, Thulesius H, Vedsted P, Perera R.

Br J Gen Pract. 2018 May;68(670):e323-e332. doi: 10.3399/bjgp18X695813. Epub 2018 Apr 23.

20.

Weight loss as a predictor of cancer in primary care: a systematic review and meta-analysis.

Nicholson BD, Hamilton W, O'Sullivan J, Aveyard P, Hobbs FR.

Br J Gen Pract. 2018 May;68(670):e311-e322. doi: 10.3399/bjgp18X695801. Epub 2018 Apr 9.

21.

Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.

Shinkins B, Primrose JN, Pugh SA, Nicholson BD, Perera R, James T, Mant D.

Br J Surg. 2018 May;105(6):658-662. doi: 10.1002/bjs.10819. Epub 2018 Mar 26. Erratum in: Br J Surg. 2019 May;106(6):728.

22.

Overtesting and undertesting in primary care: a systematic review and meta-analysis.

O'Sullivan JW, Albasri A, Nicholson BD, Perera R, Aronson JK, Roberts N, Heneghan C.

BMJ Open. 2018 Feb 11;8(2):e018557. doi: 10.1136/bmjopen-2017-018557. Review.

23.

The Suspected CANcer (SCAN) pathway: protocol for evaluating a new standard of care for patients with non-specific symptoms of cancer.

Nicholson BD, Oke J, Friedemann Smith C, Phillips JA, Lee J, Abel L, Kelly S, Gould I, Mackay T, Kaveney Z, Anthony S, Hayles S, Lasserson D, Gleeson F.

BMJ Open. 2018 Jan 21;8(1):e018168. doi: 10.1136/bmjopen-2017-018168.

24.

Weight loss as a predictor of cancer and serious disease in primary care: an ISAC-approved CPRD protocol for a retrospective cohort study using routinely collected primary care data from the UK.

Nicholson BD, Aveyard P, Hobbs FDR, Smith M, Fuller A, Perera R, Hamilton W, Stevens S, Bankhead CR.

Diagn Progn Res. 2018 Jan 10;2:1. doi: 10.1186/s41512-017-0019-9. eCollection 2018.

25.

Point-of-care Helicobacter pylori testing: primary care technology update.

Nicholson BD, Abel LM, Turner PJ, Price CP, Heneghan C, Hayward G, Plüddemann A.

Br J Gen Pract. 2017 Dec;67(665):576-577. doi: 10.3399/bjgp17X693881. No abstract available.

26.

Identifying clinical features in primary care electronic health record studies: methods for codelist development.

Watson J, Nicholson BD, Hamilton W, Price S.

BMJ Open. 2017 Nov 22;7(11):e019637. doi: 10.1136/bmjopen-2017-019637.

27.

What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial.

Shinkins B, Nicholson BD, James T, Pathiraja I, Pugh S, Perera R, Primrose J, Mant D.

Health Technol Assess. 2017 Apr;21(22):1-60. doi: 10.3310/hta21220. Review.

28.

Detecting cancer in primary care: Where does early diagnosis stop and overdiagnosis begin?

Nicholson BD.

Eur J Cancer Care (Engl). 2017 May;26(3). doi: 10.1111/ecc.12692. Epub 2017 Apr 20. No abstract available.

PMID:
28426170
29.

Can safety-netting improve cancer detection in patients with vague symptoms?

Nicholson BD, Mant D, Bankhead C.

BMJ. 2016 Nov 9;355:i5515. doi: 10.1136/bmj.i5515. No abstract available.

PMID:
28291732
30.

The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.

Shinkins B, Nicholson BD, Primrose J, Perera R, James T, Pugh S, Mant D.

PLoS One. 2017 Mar 10;12(3):e0171810. doi: 10.1371/journal.pone.0171810. eCollection 2017.

31.

The Sore Throat Test and Treat Service: speed should not substitute science.

Goyder C, Verbakel J, Hayward G, Lee J, Nicholson BD, Van den Bruel A.

Br J Gen Pract. 2017 Mar;67(656):110. doi: 10.3399/bjgp17X689545. No abstract available.

32.

Economic and clinical burden of opioid-induced nausea and vomiting.

Nicholson BD.

Postgrad Med. 2017 Jan;129(1):111-117. doi: 10.1080/00325481.2017.1243004. Epub 2016 Oct 11. Review.

PMID:
27690715
33.

Blood Measurement of Carcinoembryonic Antigen Level for Detecting Recurrence of Colorectal Cancer.

Nicholson BD, Shinkins B, Mant D.

JAMA. 2016 Sep 27;316(12):1310-1. doi: 10.1001/jama.2016.11212.

PMID:
27673308
34.

Variation in Direct Access to Tests to Investigate Cancer: A Survey of English General Practitioners.

Nicholson BD, Oke JL, Rose PW, Mant D.

PLoS One. 2016 Jul 22;11(7):e0159725. doi: 10.1371/journal.pone.0159725. eCollection 2016.

35.

International variation in adherence to referral guidelines for suspected cancer: a secondary analysis of survey data.

Nicholson BD, Mant D, Neal RD, Hart N, Hamilton W, Shinkins B, Rubin G, Rose PW.

Br J Gen Pract. 2016 Feb;66(643):e106-13. doi: 10.3399/bjgp16X683449. Epub 2016 Jan 6.

36.

Blood CEA levels for detecting recurrent colorectal cancer.

Nicholson BD, Shinkins B, Pathiraja I, Roberts NW, James TJ, Mallett S, Perera R, Primrose JN, Mant D.

Cochrane Database Syst Rev. 2015 Dec 10;(12):CD011134. doi: 10.1002/14651858.CD011134.pub2. Review.

37.

Comment on: 'Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960'--cancer predictions need more context.

Oke JL, Nicholson BD, Shinkins B.

Br J Cancer. 2015 Dec 1;113(11):1632. doi: 10.1038/bjc.2015.219. Epub 2015 Jun 23. No abstract available.

38.

Assessing the appropriateness of information on childhood fever in thermometer package leaflets: a systematic audit of thermometers available in the UK.

Hernandez J, Nicholson BD, Thompson M.

Br J Gen Pract. 2015 Jun;65(635):e366-71. doi: 10.3399/bjgp15X685261.

39.

Home-use faecal immunochemical testing: primary care diagnostic technology update.

Nicholson BD, Thompson M, Price CP, Heneghan C, Plüddemann A.

Br J Gen Pract. 2015 Mar;65(632):156-8. doi: 10.3399/bjgp15X684229. Review. No abstract available.

40.
41.

Carcinoembryonic antigen monitoring to detect recurrence of colorectal cancer: how should we interpret the test results?

Shinkins B, Nicholson BD, James TJ, Primrose JN, Mant D.

Clin Chem. 2014 Dec;60(12):1572-4. doi: 10.1373/clinchem.2014.228601. Epub 2014 Aug 26. No abstract available.

42.

Bladder cancer in women.

Nicholson BD, McGrath JS, Hamilton W.

BMJ. 2014 Mar 31;348:g2171. doi: 10.1136/bmj.g2171. Review. No abstract available.

PMID:
24687312
43.

Changes in the patterns of care of central nervous system tumours among 16-24 year olds and the effect on survival in Yorkshire between 1990 and 2009.

Nicholson BD, Picton SV, Chumas P, Dixit S, van Laar M, Loughrey C, O'Reilly G, Stark DP, Feltbower RG.

Clin Oncol (R Coll Radiol). 2013 Mar;25(3):205-14. doi: 10.1016/j.clon.2012.10.011. Epub 2012 Nov 22.

PMID:
23178199
44.

Dual-opioid therapy: changing the paradigm. Panel discussion.

Nicholson BD.

Pain Med. 2012 Mar;13 Suppl 1:S21-2. doi: 10.1111/j.1526-4637.2012.01347.x. No abstract available.

PMID:
22420603
45.

Dual-opioid therapy: changing the paradigm. Introduction.

Nicholson BD.

Pain Med. 2012 Mar;13 Suppl 1:S1-3. doi: 10.1111/j.1526-4637.2012.01342.x.

PMID:
22420601
46.

Colonoscopy for colonic wall thickening at computed tomography: a worthwhile pursuit?

Nicholson BD, Hyland R, Rembacken BJ, Denyer M, Hull MA, Tolan DJ.

Surg Endosc. 2011 Aug;25(8):2586-91. doi: 10.1007/s00464-011-1591-7. Epub 2011 Feb 27.

PMID:
21359889
47.

The social reality of migrant men with tuberculosis in Kathmandu: implications for DOT in practice.

Kirwan DE, Nicholson BD, Baral SC, Newell JN.

Trop Med Int Health. 2009 Dec;14(12):1442-7. doi: 10.1111/j.1365-3156.2009.02405.x. Epub 2009 Oct 5.

48.

Treatment of Mild-to-Moderate Acute Pain. Panel discussion.

McCarberg B, Barkin RL, Fish L, Kulich RJ, Kuritzky L, Nicholson BD, Rittenberg J, Viscusi E, Weaver AL.

Am J Ther. 2008 Nov-Dec;15 Suppl 10:S24-7. doi: 10.1097/MJT.0b013e31818be683. No abstract available.

PMID:
19127126
49.

The payer side: patient outcomes and cost.

Fish L, Nicholson BD.

Am J Ther. 2008 Nov-Dec;15 Suppl 10:S20-2; discussion S22-3. doi: 10.1097/MJT.0b013e31818bec7f. Review.

PMID:
19127125
50.

The impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet survey.

McCarberg BH, Nicholson BD, Todd KH, Palmer T, Penles L.

Am J Ther. 2008 Jul-Aug;15(4):312-20. doi: 10.1097/MJT.0b013e31818164f2.

PMID:
18645331

Supplemental Content

Loading ...
Support Center